CIK 0001728328
- Emerging growth company
Mentari Therapeutics, Inc.
Sign in to watch- Ticker
- MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 981428279
- Phone
- +1 781-887-5080
- Business address
- 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- InMed Pharmaceuticals Inc.
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market buy 10% owner bought 468,551 shares at an average $1.54 ($721,548)
- 3 Insider Initial Statement of Ownership
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Change in control · Executive or director change · Regulation FD disclosure
- 8-K Event Material agreement · Shareholder rights changed · Other events
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Shareholder rights changed · Other events
- 8-K Event Other events
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 8-K Event Delisting notice
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure
- S-3 Offering Registration Statement
- 8-K Event Regulation FD disclosure
- 8-K Event Exit or restructuring costs · Regulation FD disclosure
Page 4 of 27 · 538 filings